Correvio is publicly traded on both the NASDAQ (CORV) and TSX (CORV) stock exchanges. You will find key shareholder and financial information about Correvio in the Investor Relations section of the website. Please do not hesitate to contact Investor Relations using the information provided below if you have any further questions about the company.
Piper Jaffray Conference Slides
Latest Investor Presentation
Q3 2019 Financial Results presentation
Correvio - Third Quarter 2019 Results
Cantor Conference 2019
EVENTS
Piper Jaffray Conference Slides
Latest Investor Presentation
Q3 2019 Financial Results presentation
Correvio - Third Quarter 2019 Results
Cantor Conference 2019
Audit Committee Mandate
Board Mandate
Code of Conduct and Business Ethics
Compensation Committee Mandate
Constating Documents
Governance and Nominating Committee Mandate
Majority Voting Policy
NASDAQ Corporate Governance Exemptions
Position Description - Chair of the Board
Schedule B - Advance Notice Provision
Proxy Materials for Annual General Meeting to be held on June 18, 2019:
Notice of Meeting
Correvio 2019 Information Circular
Form of Proxy
At Correvio Pharma, we always welcome your questions or comments. Please direct any investor related enquiries to:
By following this link you will be leaving the Correvio.com website. Please note that Correvio does not take responsibility for the content displayed on other websites:
Copyright 2018 Correvio Pharma Corp. All rights reserved.
By following this link you will be leaving the Correvio.com website. Please note that Correvio does not take responsibility for the content displayed on other websites:
